Bionsight
Bioinformatics · Artificial Intelligence
Overview
Decode ProteinInteractions 10× Faster. Bionsight combines cutting-edge chemoproteomics with artificial intelligence to identify therapeutic targets with unprecedented precision, accelerating drug discovery from years to months.
Funding and backers
Backers
1
Schmidt
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Schmidt Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
CrystalsFirst reimagines small-molecule drug discovery. The MAGNET platform integrates structural biology and AI accelerating drug…
Unlocking the full potential of chemoproteomics to accelerate the discovery of new small molecules that can change the course of disease.
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
MSAID revolutionizes proteomics analysis with AI, providing cutting-edge software and data analysis services using powerful machine…
As your research partner, EpiCypher provides cutting-edge tools and services for epigenetics and chromatin biology research.
PrecisionPhage empowers you with cutting-edge phage bioinformatics software. We have phage laboratory services and an extensive phage…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors